This January 2024, we're spotlighting Bruton's tyrosine kinase (BTK) as our Clovertex Target of the ...
The cryoDuck Blog
Commentary on everything related to cryo-EM in drug discovery.
Medicine experienced a monumental moment in 2023 with the recognition of BCL11A as the 2023 Cloverte...
Amidst a flurry of big pharma deals, the Muscarinic acetylcholine receptor subtype M4 has emerged as...
Here are your MiTeGen Hottest Tweets in SBDD, and explore groundbreaking advances like SPACEtomo as ...
I was recently a panelist at the 31st Protein Structure Determination in Industry Meeting (PSDI 2023...
This November, we highlight the folate receptor alpha (FRα) as the 'Clovertex Target of the Month'. ...
This month's your MiTeGen Hottest Tweets in SBDD come with highlights across all topics including si...
For October 2023, we have the Human Epidermal growth factor Receptor 3 (HER3) as the 'Clovertex Drug...
This month, your MiTeGen Hottest Tweets in SBDD tweets come in the wake of the Ozempic frenzy. The i...
In a previous discussion, we highlighted the Manual Plunge Cooler by MiTeGen and its potential to co...